Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts NVIDIA Facing Weak Demand for New Chip as Chinese Firms Turn to Homegrown Silicon September 17, 2025 Coinbase Expands USDC Rewards to Canada September 17, 2025 Laramide Identifies Targets for 15,000 Meter Drill Program at Kazakhstan Uranium Project September 17, 2025
Laramide Identifies Targets for 15,000 Meter Drill Program at Kazakhstan Uranium Project September 17, 2025